CLUVOT

This brand name is authorized in Finland, Malta, Netherlands, Poland, Romania, Spain.

Active ingredients

The drug CLUVOT contains one active pharmaceutical ingredient (API):

1	Coagulation factor XIII UNII F7R0FBC1XD - FACTOR XIII CONCENTRATE (HUMAN)
	Factor XIII connects the amino group of lysine with glutamine via its enzymatic function (transamidase activity), thereby leading to the cross-linking of fibrin molecules. This is the final stage of blood coagulation. Fibrin cross-linking and stabilisation promote the penetration of fibroblasts and support wound healing.
	Read more about Coagulation factor XIII

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
B02BD07	Coagulation factor XIII	B Blood and blood forming organs → B02 Antihemorrhagics → B02B Vitamin K and other hemostatics → B02BD Blood coagulation factors
Discover more medicines within B02BD07

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
ES	Centro de información online de medicamentos de la AEMPS	78779
FI	Lääkealan turvallisuus- ja kehittämiskeskus	453809, 539484
MT	Medicines Authority	MA665/00201, MA665/00202
NL	Z-Index G-Standaard, PRK	119059, 119067
PL	Rejestru Produktów Leczniczych	100322841, 100322858
RO	Agenția Națională a Medicamentului și a Dispozitivelor Medicale	W61352001, W61353001